Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL CO | c15518e10vk.htm |
| EX-31.2 - EXHIBIT 31.2 - LA JOLLA PHARMACEUTICAL CO | c15518exv31w2.htm |
| EX-23.1 - EXHIBIT 23.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv23w1.htm |
| EX-21.1 - EXHIBIT 21.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv21w1.htm |
| EX-32.1 - EXHIBIT 32.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv32w1.htm |
| EX-31.1 - EXHIBIT 31.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv31w1.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.
333-106060, 333-116233, 333-131248, 333-125427, 333-143677 and 333-151825 and 333-169140) of La Jolla
Pharmaceutical Company of our report dated April 15, 2010, with respect to the 2009 consolidated
financial statements of La Jolla Pharmaceutical Company, included in this Annual Report (Form 10-K)
for the year ended December 31, 2010.
| /s/ Ernst & Young LLP | ||||
San Diego, California
April 13, 2011
April 13, 2011